Growth Metrics

Enanta Pharmaceuticals (ENTA) Revenue Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 64.24%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.82%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 19.04%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3,790.58%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 14.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.96%
Dec 31, 2025 9.76%
Sep 30, 2025 3.55%
Jun 30, 2025 1.91%
Mar 31, 2025 -12.48%
Dec 31, 2024 -5.80%
Sep 30, 2024 -22.84%
Jun 30, 2024 -4.88%
Mar 31, 2024 -4.16%
Dec 31, 2023 -23.67%
Sep 30, 2023 -6.82%
Jun 30, 2023 -3.01%
Mar 31, 2023 -4.92%
Dec 31, 2022 -14.70%
Sep 30, 2022 -13.82%
Jun 30, 2022 -9.92%
Mar 31, 2022 -7.03%
Dec 31, 2021 -12.90%
Sep 30, 2021 -0.24%
Jun 30, 2021 15.93%
Mar 31, 2021 -27.11%
Dec 31, 2020 -39.62%
Sep 30, 2020 -53.95%
Jun 30, 2020 -57.96%
Mar 31, 2020 -30.31%
Dec 31, 2019 -24.78%
Sep 30, 2019 -23.65%
Jun 30, 2019 -22.52%
Mar 31, 2019 -10.03%
Dec 31, 2018 83.38%
Sep 30, 2018 -11.49%
Jun 30, 2018 662.38%
Mar 31, 2018 391.67%
Dec 31, 2017 265.83%
Sep 30, 2017 491.29%
Jun 30, 2017 -46.27%
Mar 31, 2017 -31.11%
Dec 31, 2016 -78.50%
Sep 30, 2016 -10.93%
Jun 30, 2016 20.51%
Mar 31, 2016 -77.33%
Dec 31, 2015 -37.49%
Sep 30, 2015 446.68%
Jun 30, 2015 -72.42%
Mar 31, 2015 2,555.88%
Dec 31, 2014 8,578.39%
Sep 30, 2014 95.48%
Jun 30, 2014 2,450.09%
Mar 31, 2014 80.60%
Dec 31, 2013 -96.79%
Sep 30, 2013 -27.40%
Jun 30, 2013 -35.13%
Mar 31, 2013 -96.73%